generic drugmakers, said it needed more details about Trump’s move and urged the administration to address existing barriers to expanding domestic production.
“We need to understand more the specifics of the policy, but the generics industry is committed to pursuing policies that support and stabilize both the industry and the access necessary to ensure continue reading …
